NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the upcoming Bio-IT World...
Syntekabio said Thursday that its COVID-19 combination treatment candidates have displayed therapeutic effects twice as strong as remdesivir in animal tests.